Enrollment of Females in Randomized Trials for Glucagon-Like Peptide 1 Receptor Agonists
There is a declining trend in the proportion of females enrolled in GLP-1RA RCTs compared to men. Females are fairly represented among RCTs done in heart failure and chronic kidney disease, however, significantly underrepresented for studies on coronary heart disease.
Authors
- Francisco López-Jiménez (ORCID: https://orcid.org/0000-0001-5788-9734)
- Kyla Lara-Breitinger (ORCID: https://orcid.org/0000-0001-9724-3065)
- Martha Gulati (ORCID: https://orcid.org/0000-0003-0735-9756)
- John Vincent Magalong (ORCID: https://orcid.org/0000-0002-2276-0647)
- Frederick Berro Rivera (ORCID: https://orcid.org/0000-0001-9100-0724)
- Elisa Aguirre (ORCID: https://orcid.org/0000-0003-4096-5109)
- Mario B. Prado (ORCID: https://orcid.org/0000-0003-0465-0943)
- Mc John Caro Ybañez
- Janos Marc M. Rubia
- Polyn Luz S Pine
- Ana Patricia Ting Cañares
- Allyn Ralph Hiyas
Institutions
- Lincoln Medical Center (US)
- Mayo Clinic (US)
- Ateneo de Manila University (PH)
- San Beda University (PH)
- Cedars-Sinai Smidt Heart Institute (US)
- University of the Philippines Manila (PH)
Publication Details
- Journal
- JACC Advances
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1016/j.jacadv.2024.101386
- Citations
- 5
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.79